Allogeneic Hematopoietic Stem Cell Transplantation Improved Survival for Adult Core Binding Factor Acute Myelogenous Leukemia Patients with Intermediate- and Adverse-Risk Genetics in the 2017 European LeukemiaNet-Reference-Cited by-同舟云学术

Allogeneic Hematopoietic Stem Cell Transplantation Improved Survival for Adult Core Binding Factor Acute Myelogenous Leukemia Patients with Intermediate- and Adverse-Risk Genetics in the 2017 European LeukemiaNet

Published:2021-02 Issue:2 Volume:27 Page:173.e1-173.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Wang Tanzhen,Chen Sifan,Chen Jia,Liu Tianhui,Zhang Tongtong,Qiu Huiying,Sun Aining,Chen Suning,Wu Depei,Xu Yang

Funder

Priority Academic Program Development of Jiangsu Higher Education Institutions

National Key Research and Development Program of China

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference53 articles.

1. Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts;Peterson;Blood,2007

2. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells;Liu;Genes Chromosomes Cancer,1996

3. inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations;Schwind;Blood,2013

4. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98;von Neuhoff;J Clin Oncol,2010

5. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials;Grimwade;Blood,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The core concepts of core binding factor acute myeloid leukemia: Current considerations for prognosis and treatment;Blood Reviews;2023-11

2. Therapy-related core binding factor acute myeloid leukemia;International Journal of Hematologic Oncology;2023-03

3. Combination of KIT and FLT3‐ ITD mutation status with minimal residual disease levels guides treatment strategy for adult patients with inv(16) acute myeloid leukemia in first complete remission;Hematological Oncology;2022-05-15

4. Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective;Frontiers in Oncology;2021-10-28